Carrimycin(CA),sanctioned by China’s National Medical Products Administration(NMPA)in 2019 for treating acute bronchitis and sinusitis,has recently been observed to exhibit multifaceted biological activities,encompas...Carrimycin(CA),sanctioned by China’s National Medical Products Administration(NMPA)in 2019 for treating acute bronchitis and sinusitis,has recently been observed to exhibit multifaceted biological activities,encompassing anti-inflammatory,antiviral,and anti-tumor properties.Despite these applications,its efficacy in sepsis treatment remains unexplored.This study introduces a novel function of CA,demonstrating its capacity to mitigate sepsis induced by lipopolysaccharide(LPS)and cecal ligation and puncture(CLP)in mice models.Our research employed in vitro assays,real-time quantitative polymerase chain reaction(RT-qPCR),and RNA-seq analysis to establish that CA significantly reduces the levels of pro-inflammatory cytokines,namely tumor necrosis factor-alpha(TNF-α),interleukin 1 beta(IL-1β),and interleukin 6(IL-6),in response to LPS stimulation.Additionally,Western blotting and immunofluorescence assays revealed that CA impedes Nuclear Factor Kappa B(NF-κB)activation in LPS-stimulated RAW264.7 cells.Complementing these findings,in vivo experiments demonstrated that CA effectively alleviates LPS-and CLP-triggered organ inflammation in C57BL/6 mice.Further insights were gained through 16S sequencing,highlighting CA’s pivotal role in enhancing gut microbiota diversity and modulating metabolic pathways,particularly by augmenting the production of short-chain fatty acids in mice subjected to CLP.Notably,a comparative analysis revealed that CA’s anti-inflammatory efficacy surpasses that of equivalent doses of aspirin(ASP)and TIENAM.Collectively,these findings suggest that CA exhibits significant therapeutic potential in sepsis treatment.This discovery provides a foundational theoretical basis for the clinical application of CA in sepsis management.展开更多
Cardiac dysfunction, a common consequence of sepsis, is the major contribution to morbidity and mortality in patients. Sodium tanshinone IIA sulfonate(STS) is a water-soluble derivative of Tanshinone IIA(TA), a main a...Cardiac dysfunction, a common consequence of sepsis, is the major contribution to morbidity and mortality in patients. Sodium tanshinone IIA sulfonate(STS) is a water-soluble derivative of Tanshinone IIA(TA), a main active component of Salvia miltiorrhiza Bunge, which has been widely used in China for the treatment of cardiovascular and cerebral system diseases. In the present study, the effect of STS on sepsis-induced cardiac dysfunction was investigated and its effect on survival rate of rats with sepsis was also evaluated. STS treatment could significantly decrease the serum levels of C-reactive protein(CRP), procalcitonin(PCT), cardiac troponin Ⅰ(cTn-Ⅰ), cardiac troponin T(cTn-T), and brain natriuretic peptide(BNP) in cecal ligation and puncture(CLP)-induced) septic rats and improve left ventricular function, particularly at 48 and 72 h after CLP. As the pathogenesis of septic myocardial dysfunction is attributable to dysregulated systemic inflammatory responses, several key cytokines, including tumor necrosis factor-α(TNF-α), interleukin-1β(IL-1β), interleukin-6(IL-6), interleukin-10(IL-10) and high mobility group protein B1(HMGB1), were detected to reveal the possible mechanism of attenuation of septic myocardial dysfunction after being treated by STS. Our study showed that STS, especially at a high dose(15 mg×kg–1), could efficiently suppress inflammatory responses in myocardium and reduce myocardial necrosis through markedly reducing production of myocardial TNF-α, IL-6 and HMGB1. STS significantly improved the 18-day survival rate of rats with sepsis from 0% to 30%(P < 0.05). Therefore, STS could suppress inflammatory responses and improve left ventricular function in rats with sepsis, suggesting that it may be developed for the treatment of sepsis.展开更多
Background：Recent studies have indicated that autophagy is involved in sepsis-induced myocardial dysfunction.This study aimed to investigate the change of autophagy in cecal ligation and puncture （CLP）-induced myoc...Background：Recent studies have indicated that autophagy is involved in sepsis-induced myocardial dysfunction.This study aimed to investigate the change of autophagy in cecal ligation and puncture （CLP）-induced myocardium dysfunction and its relationship with mammalian target of rapamycin （mTOR） pathway.Methods：Totally,12 rats were randomly divided into CLP group or sham-operated （SHAM） group.Cardiac tissues were harvested 18 h after CLP or sham operation.Pathology was detected by hematoxylin and eosin staining,cardiac functions by echocardiography,distribution ofmicrotubule-associated protein light chain 3 type Ⅱ （LC3II） by immunohistochemical staining,and autophagic vacuoles by transmission electron microscopy.Moreover,phosphorylation of mTOR （p-mTOR）,phosphorylation of S6 kinase-1 （PS6K1）,and LC3II and p62 expression were measured by western blotting.Pearson＇s correlation coefficient was used to analyze the correlation of two parameters.Results：The results by pathology and echocardiography revealed that there was obvious myocardial injury in CLP rats （left ventricle ejection fraction：SHAM 0.76 ± 0.06 vs.CLP 0.59 ± 0.l l,P 〈 0.01;fractional shortening：SHAM 0.51 ± 0.09 vs.CLP 0.37 ± 0.06,P 〈 0.05）.We also found that the autophagy process was elevated by CLE the ratio of LC3II/LC3I was increased （P 〈 0.05） while the expression of p62 was decreased （P 〈 0.05） in the CLP rats,and there were also more autophagosomes and autolysosomes in the CLP rats.Furthermore,the mTOR pathway in CLP myocardium was inhibited when compared with the sham-operated rats;p-mTOR （P 〈 0.01） and PS6K 1 （P 〈 0.05） were both significantly suppressed following CLP challenge.Interestingly,we found that the mTOR pathway was closely correlated with the autophagy processes.In our study,while p-mTOR in the myocardium was significantly correlated with p62 （r=0.66,P =0.02）,PS6K1 was significantly positively correlated with p62 （r =0.70,P =0.01） and negatively correlated with LC31I （r =-0.71,P =0.01）.Conclusions：The autophagy process in the myocardium was accelerated in CLP rats,which was closely correlated with the inhibition of the mTOR pathway.展开更多
本文主要对大鼠、小鼠盲肠结扎穿刺术(CLP)脓毒血症模型进行分析,从模式动物角度发现潜在的脓毒血症相关基因,为脓毒血症诊疗提供理论依据。从NCBI-Gene Expression Omnibus数据库下载原始微阵列数据集,然后纳入盲肠结扎穿刺术脓毒血症...本文主要对大鼠、小鼠盲肠结扎穿刺术(CLP)脓毒血症模型进行分析,从模式动物角度发现潜在的脓毒血症相关基因,为脓毒血症诊疗提供理论依据。从NCBI-Gene Expression Omnibus数据库下载原始微阵列数据集,然后纳入盲肠结扎穿刺术脓毒血症及假手术组模型数据。运用生物信息学方法将数据标准化处理后,筛选差异基因进行富集分析和通路分析,并构建蛋白质相互作用关系网络,筛选出具有重要生理调节功能的核心蛋白质和关键候选基因。通过大鼠盲肠穿刺脓毒血症诱导后肝组织的差异基因表达芯片筛选,共获得350个能上调1.5倍及以上的差异基因,1337个能下调2倍及以上的差异基因;通过小鼠盲肠穿刺脓毒血症诱导后肝组织的差异基因表达芯片筛选,获得3532个上调1.5倍及以上的差异基因,4020个下调1.5倍及以上的差异基因;对上述芯片结果的差异基因取交集,得到29个共同上调表达1.5倍以上的差异基因和84个共同下调表达1.5倍以上的差异基因。利用String数据库对上述基因进行蛋白质-蛋白质的相互作用(PPI)网络分析,并利用David数据库从生物过程(BP)、分子功能(MF)、细胞组分(CC)和KEGG(Kyoto encyclopedia of genes and genomes)通路4个角度进行基因功能分析,发现共有10条通路与脓毒血症肝组织关系密切,其中最主要的通路为丝裂原活化蛋白激酶(MAPK)通路,其次,缺氧诱导因子1(HIF-1)、叉形头转录因子的O亚型(FoxO)、乙型肝炎、血小板激活及胆汁分泌等通路调控也与脓毒血症相关。本研究为进一步探讨脓毒血症相关病理生理机制及诊疗方法提供了理论基础。展开更多
目的观察青蒿素(artemisinin,ART)对脓毒症大鼠肺组织损伤的影响。方法采用盲肠结扎穿孔术(cecal ligation and puncture,CLP)制作大鼠脓毒症模型,动物分为正常对照组、CLP组和青蒿素治疗(ART)组,分别于CLP术后2、6、12、24、48、72h活...目的观察青蒿素(artemisinin,ART)对脓毒症大鼠肺组织损伤的影响。方法采用盲肠结扎穿孔术(cecal ligation and puncture,CLP)制作大鼠脓毒症模型,动物分为正常对照组、CLP组和青蒿素治疗(ART)组,分别于CLP术后2、6、12、24、48、72h活杀大鼠取肺组织,匀浆后动态浊度鲎试验法检测内毒素(lipopolysaccharide,LPS)水平,ELISA法检测TNF-α和IL-6的含量,实时荧光定量反转录聚合酶链反应(real-time RT-PCR)检测肺组织TNF-α和IL-6 mRNA的表达,光镜下观察肺组织的病理改变。结果CLP术后,ART组大鼠肺组织匀浆LPS、TNF-α和IL-6含量较CLP组明显降低(P<0.05,P<0.01),TNF-α和IL-6 mRNA的表达也显著低于CLP组(P<0.05,P<0.01),24h肺组织的病理损伤明显减轻。结论青蒿素可能通过降低脓毒症大鼠肺组织局部的LPS水平,抑制和减少了TNF-α和IL-6等促炎细胞因子的表达和释放,进而减轻肺组织的损伤。展开更多
目的研究虎杖苷对小鼠脓毒症致急性肝损伤的保护作用,并初步探讨其机制。方法采用盲肠结扎穿孔(cecal ligation and puncture,CLP)小鼠脓毒症模型,并设假手术对照组。在CLP手术前1h,采用不同剂量虎杖苷(50、100、300mg/kg)干预,随后每6...目的研究虎杖苷对小鼠脓毒症致急性肝损伤的保护作用,并初步探讨其机制。方法采用盲肠结扎穿孔(cecal ligation and puncture,CLP)小鼠脓毒症模型,并设假手术对照组。在CLP手术前1h,采用不同剂量虎杖苷(50、100、300mg/kg)干预,随后每6h观察小鼠一般情况,24h后处死存活小鼠,收集血清和肝组织样本。分别采用比色法检测血清丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)活性;采用酶联免疫法检测血清肿瘤坏死因子-α(tumor necrosis factor-alpha,TNF-α)含量;采用免疫印迹法检测肝组织环氧合酶-2(cyclooxygenase-2,COX-2)表达;并取部分肝组织进行病理组织学分析。结果 CLP后24h,小鼠死亡率高达50%,生化指标和肝脏病理显示病变明显,模型成功率达90%,相对于假手术组,血清ALT、AST活性、TNF-α水平和肝组织中COX-2蛋白表达显著升高(P<0.01);虎杖苷呈剂量依赖地改善脓毒症诱导的死亡率,抑制ALT、AST活性和TNF-α升高(P<0.05),降低肝组织中COX-2表达,减轻肝脏病理损伤。结论虎杖苷有效地保护脓毒症诱导的急性肝损伤,其作用机制可能通过抑制TNF-α生成和COX-2的表达。展开更多
基金supported by the Excellent Young Scholars Cultivation Project of Fujian Medical University Union Hospital in China(No.2022XH031)the National Natural Science Foundation of China(No.82203439)the Natural Science Foundation of Fujian Province(No.2022J01263).
文摘Carrimycin(CA),sanctioned by China’s National Medical Products Administration(NMPA)in 2019 for treating acute bronchitis and sinusitis,has recently been observed to exhibit multifaceted biological activities,encompassing anti-inflammatory,antiviral,and anti-tumor properties.Despite these applications,its efficacy in sepsis treatment remains unexplored.This study introduces a novel function of CA,demonstrating its capacity to mitigate sepsis induced by lipopolysaccharide(LPS)and cecal ligation and puncture(CLP)in mice models.Our research employed in vitro assays,real-time quantitative polymerase chain reaction(RT-qPCR),and RNA-seq analysis to establish that CA significantly reduces the levels of pro-inflammatory cytokines,namely tumor necrosis factor-alpha(TNF-α),interleukin 1 beta(IL-1β),and interleukin 6(IL-6),in response to LPS stimulation.Additionally,Western blotting and immunofluorescence assays revealed that CA impedes Nuclear Factor Kappa B(NF-κB)activation in LPS-stimulated RAW264.7 cells.Complementing these findings,in vivo experiments demonstrated that CA effectively alleviates LPS-and CLP-triggered organ inflammation in C57BL/6 mice.Further insights were gained through 16S sequencing,highlighting CA’s pivotal role in enhancing gut microbiota diversity and modulating metabolic pathways,particularly by augmenting the production of short-chain fatty acids in mice subjected to CLP.Notably,a comparative analysis revealed that CA’s anti-inflammatory efficacy surpasses that of equivalent doses of aspirin(ASP)and TIENAM.Collectively,these findings suggest that CA exhibits significant therapeutic potential in sepsis treatment.This discovery provides a foundational theoretical basis for the clinical application of CA in sepsis management.
文摘Cardiac dysfunction, a common consequence of sepsis, is the major contribution to morbidity and mortality in patients. Sodium tanshinone IIA sulfonate(STS) is a water-soluble derivative of Tanshinone IIA(TA), a main active component of Salvia miltiorrhiza Bunge, which has been widely used in China for the treatment of cardiovascular and cerebral system diseases. In the present study, the effect of STS on sepsis-induced cardiac dysfunction was investigated and its effect on survival rate of rats with sepsis was also evaluated. STS treatment could significantly decrease the serum levels of C-reactive protein(CRP), procalcitonin(PCT), cardiac troponin Ⅰ(cTn-Ⅰ), cardiac troponin T(cTn-T), and brain natriuretic peptide(BNP) in cecal ligation and puncture(CLP)-induced) septic rats and improve left ventricular function, particularly at 48 and 72 h after CLP. As the pathogenesis of septic myocardial dysfunction is attributable to dysregulated systemic inflammatory responses, several key cytokines, including tumor necrosis factor-α(TNF-α), interleukin-1β(IL-1β), interleukin-6(IL-6), interleukin-10(IL-10) and high mobility group protein B1(HMGB1), were detected to reveal the possible mechanism of attenuation of septic myocardial dysfunction after being treated by STS. Our study showed that STS, especially at a high dose(15 mg×kg–1), could efficiently suppress inflammatory responses in myocardium and reduce myocardial necrosis through markedly reducing production of myocardial TNF-α, IL-6 and HMGB1. STS significantly improved the 18-day survival rate of rats with sepsis from 0% to 30%(P < 0.05). Therefore, STS could suppress inflammatory responses and improve left ventricular function in rats with sepsis, suggesting that it may be developed for the treatment of sepsis.
基金The work was supported by a grant of the National Natural Science Foundation of China （No. 81601657）.
文摘Background：Recent studies have indicated that autophagy is involved in sepsis-induced myocardial dysfunction.This study aimed to investigate the change of autophagy in cecal ligation and puncture （CLP）-induced myocardium dysfunction and its relationship with mammalian target of rapamycin （mTOR） pathway.Methods：Totally,12 rats were randomly divided into CLP group or sham-operated （SHAM） group.Cardiac tissues were harvested 18 h after CLP or sham operation.Pathology was detected by hematoxylin and eosin staining,cardiac functions by echocardiography,distribution ofmicrotubule-associated protein light chain 3 type Ⅱ （LC3II） by immunohistochemical staining,and autophagic vacuoles by transmission electron microscopy.Moreover,phosphorylation of mTOR （p-mTOR）,phosphorylation of S6 kinase-1 （PS6K1）,and LC3II and p62 expression were measured by western blotting.Pearson＇s correlation coefficient was used to analyze the correlation of two parameters.Results：The results by pathology and echocardiography revealed that there was obvious myocardial injury in CLP rats （left ventricle ejection fraction：SHAM 0.76 ± 0.06 vs.CLP 0.59 ± 0.l l,P 〈 0.01;fractional shortening：SHAM 0.51 ± 0.09 vs.CLP 0.37 ± 0.06,P 〈 0.05）.We also found that the autophagy process was elevated by CLE the ratio of LC3II/LC3I was increased （P 〈 0.05） while the expression of p62 was decreased （P 〈 0.05） in the CLP rats,and there were also more autophagosomes and autolysosomes in the CLP rats.Furthermore,the mTOR pathway in CLP myocardium was inhibited when compared with the sham-operated rats;p-mTOR （P 〈 0.01） and PS6K 1 （P 〈 0.05） were both significantly suppressed following CLP challenge.Interestingly,we found that the mTOR pathway was closely correlated with the autophagy processes.In our study,while p-mTOR in the myocardium was significantly correlated with p62 （r=0.66,P =0.02）,PS6K1 was significantly positively correlated with p62 （r =0.70,P =0.01） and negatively correlated with LC31I （r =-0.71,P =0.01）.Conclusions：The autophagy process in the myocardium was accelerated in CLP rats,which was closely correlated with the inhibition of the mTOR pathway.
文摘本文主要对大鼠、小鼠盲肠结扎穿刺术(CLP)脓毒血症模型进行分析,从模式动物角度发现潜在的脓毒血症相关基因,为脓毒血症诊疗提供理论依据。从NCBI-Gene Expression Omnibus数据库下载原始微阵列数据集,然后纳入盲肠结扎穿刺术脓毒血症及假手术组模型数据。运用生物信息学方法将数据标准化处理后,筛选差异基因进行富集分析和通路分析,并构建蛋白质相互作用关系网络,筛选出具有重要生理调节功能的核心蛋白质和关键候选基因。通过大鼠盲肠穿刺脓毒血症诱导后肝组织的差异基因表达芯片筛选,共获得350个能上调1.5倍及以上的差异基因,1337个能下调2倍及以上的差异基因;通过小鼠盲肠穿刺脓毒血症诱导后肝组织的差异基因表达芯片筛选,获得3532个上调1.5倍及以上的差异基因,4020个下调1.5倍及以上的差异基因;对上述芯片结果的差异基因取交集,得到29个共同上调表达1.5倍以上的差异基因和84个共同下调表达1.5倍以上的差异基因。利用String数据库对上述基因进行蛋白质-蛋白质的相互作用(PPI)网络分析,并利用David数据库从生物过程(BP)、分子功能(MF)、细胞组分(CC)和KEGG(Kyoto encyclopedia of genes and genomes)通路4个角度进行基因功能分析,发现共有10条通路与脓毒血症肝组织关系密切,其中最主要的通路为丝裂原活化蛋白激酶(MAPK)通路,其次,缺氧诱导因子1(HIF-1)、叉形头转录因子的O亚型(FoxO)、乙型肝炎、血小板激活及胆汁分泌等通路调控也与脓毒血症相关。本研究为进一步探讨脓毒血症相关病理生理机制及诊疗方法提供了理论基础。
